X0306 4 2020-10-01 0 0001434316 FATE THERAPEUTICS INC FATE 0001655472 TAHL CINDY C/O FATE THERAPEUTICS, INC.; 3535 GENERAL ATOMICS COURT #200 SAN DIEGO CA 92121 0 1 0 0 General Counsel and Secretary Common stock 2020-10-01 4 M 0 35000 2.73 A 134518 D Common stock 2020-10-01 4 S 0 21757 40.2584 D 112761 D Common stock 2020-10-01 4 S 0 6260 41.0917 D 106501 D Common stock 2020-10-01 4 S 0 6983 41.9489 D 99518 D Stock Option (right to buy) 2.73 2020-10-01 4 M 0 35000 D 2027-01-03 Common Stock 35000 115000 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020. Represents the weighted average sale price of the shares sold ranging from $39.65 to $40.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $40.65 to $41.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Represents the weighted average sale price of the shares sold ranging from $41.66 to $42.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. The shares subject to this option shall vest and become exercisable in 48 monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021. Not applicable. /s/ Cindy R. Tahl 2020-10-02